Go Pro

Surgery Partners (SGRY) Competitors

Surgery Partners logo
$14.05 +0.10 (+0.72%)
Closing price 04:00 PM Eastern
Extended Trading
$14.04 -0.01 (-0.04%)
As of 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SGRY vs. PACS, CON, BKD, ACHC, and SNDA

Should you buy Surgery Partners stock or one of its competitors? Surgery Partners's main competitors and comparable companies include PACS Group (PACS), Concentra Group Holdings Parent (CON), Brookdale Senior Living (BKD), Acadia Healthcare (ACHC), and Sonida Senior Living (SNDA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare facilities" industry.

How does Surgery Partners compare to PACS Group?

PACS Group (NYSE:PACS) and Surgery Partners (NASDAQ:SGRY) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

PACS Group has a net margin of 4.85% compared to Surgery Partners' net margin of -2.63%. PACS Group's return on equity of 29.55% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.85% 29.55% 5.23%
Surgery Partners -2.63%0.88%0.34%

PACS Group has a beta of -0.08, meaning that its share price is 108% less volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.92, meaning that its share price is 92% more volatile than the broader market.

In the previous week, PACS Group had 11 more articles in the media than Surgery Partners. MarketBeat recorded 15 mentions for PACS Group and 4 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.51 beat PACS Group's score of 0.40 indicating that Surgery Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
9 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Surgery Partners
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

PACS Group has higher revenue and earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.32$191.54M$1.7225.56
Surgery Partners$3.31B0.56-$77.90M-$0.70N/A

PACS Group presently has a consensus target price of $56.00, indicating a potential upside of 27.39%. Surgery Partners has a consensus target price of $19.45, indicating a potential upside of 38.47%. Given Surgery Partners' higher probable upside, analysts clearly believe Surgery Partners is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.00
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

Summary

PACS Group beats Surgery Partners on 11 of the 15 factors compared between the two stocks.

How does Surgery Partners compare to Concentra Group Holdings Parent?

Surgery Partners (NASDAQ:SGRY) and Concentra Group Holdings Parent (NYSE:CON) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

Surgery Partners has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Concentra Group Holdings Parent has lower revenue, but higher earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B0.56-$77.90M-$0.70N/A
Concentra Group Holdings Parent$2.16B2.05$166.41M$1.5522.43

Surgery Partners presently has a consensus target price of $19.45, suggesting a potential upside of 38.47%. Concentra Group Holdings Parent has a consensus target price of $37.00, suggesting a potential upside of 6.40%. Given Surgery Partners' higher probable upside, research analysts clearly believe Surgery Partners is more favorable than Concentra Group Holdings Parent.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

Concentra Group Holdings Parent has a net margin of 8.69% compared to Surgery Partners' net margin of -2.63%. Concentra Group Holdings Parent's return on equity of 47.81% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.63% 0.88% 0.34%
Concentra Group Holdings Parent 8.69%47.81%7.04%

In the previous week, Surgery Partners had 3 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 4 mentions for Surgery Partners and 1 mentions for Concentra Group Holdings Parent. Surgery Partners' average media sentiment score of 1.51 beat Concentra Group Holdings Parent's score of 1.27 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Concentra Group Holdings Parent
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Concentra Group Holdings Parent beats Surgery Partners on 8 of the 13 factors compared between the two stocks.

How does Surgery Partners compare to Brookdale Senior Living?

Surgery Partners (NASDAQ:SGRY) and Brookdale Senior Living (NYSE:BKD) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Surgery Partners has a net margin of -2.63% compared to Brookdale Senior Living's net margin of -4.53%. Surgery Partners' return on equity of 0.88% beat Brookdale Senior Living's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgery Partners-2.63% 0.88% 0.34%
Brookdale Senior Living -4.53%-15,050.32%-1.09%

In the previous week, Brookdale Senior Living had 6 more articles in the media than Surgery Partners. MarketBeat recorded 10 mentions for Brookdale Senior Living and 4 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.51 beat Brookdale Senior Living's score of 1.14 indicating that Surgery Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Surgery Partners
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Brookdale Senior Living
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Surgery Partners has higher revenue and earnings than Brookdale Senior Living. Brookdale Senior Living is trading at a lower price-to-earnings ratio than Surgery Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgery Partners$3.31B0.56-$77.90M-$0.70N/A
Brookdale Senior Living$3.05B0.96-$262.69M-$0.58N/A

Surgery Partners currently has a consensus target price of $19.45, indicating a potential upside of 38.47%. Brookdale Senior Living has a consensus target price of $17.40, indicating a potential upside of 42.24%. Given Brookdale Senior Living's stronger consensus rating and higher probable upside, analysts clearly believe Brookdale Senior Living is more favorable than Surgery Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55
Brookdale Senior Living
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Surgery Partners has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market. Comparatively, Brookdale Senior Living has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Summary

Surgery Partners beats Brookdale Senior Living on 9 of the 15 factors compared between the two stocks.

How does Surgery Partners compare to Acadia Healthcare?

Acadia Healthcare (NASDAQ:ACHC) and Surgery Partners (NASDAQ:SGRY) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Surgery Partners has lower revenue, but higher earnings than Acadia Healthcare. Surgery Partners is trading at a lower price-to-earnings ratio than Acadia Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acadia Healthcare$3.31B0.84-$1.10B-$12.45N/A
Surgery Partners$3.31B0.56-$77.90M-$0.70N/A

Acadia Healthcare has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.92, indicating that its stock price is 92% more volatile than the broader market.

In the previous week, Acadia Healthcare had 5 more articles in the media than Surgery Partners. MarketBeat recorded 9 mentions for Acadia Healthcare and 4 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.51 beat Acadia Healthcare's score of 0.69 indicating that Surgery Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Acadia Healthcare
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Surgery Partners
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Acadia Healthcare presently has a consensus target price of $29.85, indicating a potential downside of 0.08%. Surgery Partners has a consensus target price of $19.45, indicating a potential upside of 38.47%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Acadia Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acadia Healthcare
2 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.47
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

Surgery Partners has a net margin of -2.63% compared to Acadia Healthcare's net margin of -33.44%. Acadia Healthcare's return on equity of 6.19% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Acadia Healthcare-33.44% 6.19% 2.42%
Surgery Partners -2.63%0.88%0.34%

Summary

Acadia Healthcare and Surgery Partners tied by winning 7 of the 14 factors compared between the two stocks.

How does Surgery Partners compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Surgery Partners (NASDAQ:SGRY) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Sonida Senior Living had 2 more articles in the media than Surgery Partners. MarketBeat recorded 6 mentions for Sonida Senior Living and 4 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 1.51 beat Sonida Senior Living's score of 0.95 indicating that Surgery Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sonida Senior Living
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Surgery Partners
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

87.6% of Sonida Senior Living shares are owned by institutional investors. 39.3% of Sonida Senior Living shares are owned by insiders. Comparatively, 2.0% of Surgery Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sonida Senior Living has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Surgery Partners has a beta of 1.92, indicating that its share price is 92% more volatile than the broader market.

Surgery Partners has a net margin of -2.63% compared to Sonida Senior Living's net margin of -23.27%. Surgery Partners' return on equity of 0.88% beat Sonida Senior Living's return on equity.

Company Net Margins Return on Equity Return on Assets
Sonida Senior Living-23.27% -25.53% -6.67%
Surgery Partners -2.63%0.88%0.34%

Sonida Senior Living presently has a consensus price target of $47.50, indicating a potential upside of 15.95%. Surgery Partners has a consensus price target of $19.45, indicating a potential upside of 38.47%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts plainly believe Surgery Partners is more favorable than Sonida Senior Living.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sonida Senior Living
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Surgery Partners
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

Sonida Senior Living has higher earnings, but lower revenue than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Sonida Senior Living, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sonida Senior Living$525.97M3.74-$70.78M-$6.19N/A
Surgery Partners$3.31B0.56-$77.90M-$0.70N/A

Summary

Surgery Partners beats Sonida Senior Living on 10 of the 16 factors compared between the two stocks.

Get Surgery Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGRY vs. The Competition

MetricSurgery PartnersHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.84B$9.93B$7.31B$12.77B
Dividend YieldN/A2.55%2.54%10.78%
P/E Ratio-20.0734.45271.2324.19
Price / Sales0.565.06696.77129.00
Price / Cash8.5124.6429.0336.89
Price / Book0.585.4611.336.52
Net Income-$77.90M$309.96M$3.46B$347.63M
7 Day Performance-1.33%0.94%3.26%1.60%
1 Month Performance-10.68%1.74%8.85%5.27%
1 Year Performance-39.02%16.19%27.68%17.87%

Surgery Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGRY
Surgery Partners
4.6457 of 5 stars
$14.05
+0.7%
$19.45
+38.5%
-41.0%$1.84B$3.31BN/A16,000
PACS
PACS Group
4.5448 of 5 stars
$44.47
+0.1%
$56.00
+25.9%
+268.6%$7.03B$5.29B25.8547,455
CON
Concentra Group Holdings Parent
4.1898 of 5 stars
$35.42
0.0%
$37.00
+4.5%
+48.1%$4.52B$2.16B22.8513,133
BKD
Brookdale Senior Living
3.1378 of 5 stars
$12.26
-3.0%
$17.40
+41.9%
+57.2%$3.02B$3.19BN/A36,000
ACHC
Acadia Healthcare
1.5238 of 5 stars
$30.00
-2.7%
$29.85
-0.5%
+28.0%$2.87B$3.31BN/A25,000

Related Companies and Tools


This page (NASDAQ:SGRY) was last updated on 8/25/2026 by MarketBeat.com Staff.
From Our Partners